# A Study of XmAb23104 in People With Sarcoma

> **NCT05879185** · PHASE2 · TERMINATED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 6 (actual)

## Conditions studied

- Sarcoma

## Interventions

- **BIOLOGICAL:** XmAb23104

## Key facts

- **NCT ID:** NCT05879185
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-04-06
- **Primary completion:** 2024-07-19
- **Final completion:** 2024-07-19
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Vendor decided study to be closed early
- **Last updated:** 2026-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05879185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05879185, "A Study of XmAb23104 in People With Sarcoma". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05879185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*